子宫内膜癌微创分期中前哨淋巴结活检的应用差异及围手术期结局
基于美国国家癌症数据库的回顾性队列研究,纳入2012至2016年接受微创手术分期的T1NxM0子宫内膜癌患者67365例,其中6356例(9.4%)接受了前哨淋巴结活检(SLNB),使用率从2.8%升至16.3%。研究发现SLNB使用存在种族、族裔、保险、县密度和收入差异,且SLNB与较低的转开腹手术风险、住院超过1天风险及非计划再入院风险相关。
要点
- SLNB使用率从2012年2.8%升至2016年16.3%,存在种族、保险、收入等多方面差异。
- SLNB(±淋巴结清扫)较直接淋巴结清扫降低转开腹手术风险(ORITT=0.53)。
- SLNB与较低住院超过1天风险(ORITT=0.51)和非计划再入院风险(ORPP=0.52)相关。
核心结论
- SLNB的使用存在显著差异,且这种创伤较小的技术可能与较低的某些围手术期并发症发生率相关。
- 公平获得这一新兴技术可能减少差异结局。
研究设计与样本
- 回顾性队列研究,使用美国国家癌症数据库,选取2012年至2016年接受微创手术分期的T1NxM0子宫内膜癌患者。
- 共纳入67365例患者,其中6356例(9.4%)接受了SLNB。
- 进行了倾向性匹配,并使用逻辑回归评估SLNB与围手术期结局的关联。
主要发现
- SLNB使用率从2012年的2.8%上升至2016年的16.3%。
- 使用差异:黑人7.0% vs 非黑人9.4%;西班牙裔8.3% vs 非西班牙裔9.5%;无保险6.0% vs 有保险9.5%;农村3.7% vs 都市9.8%;收入最低四分位7.0% vs 最高四分位11.8%。
- 转开腹手术风险:仅SLNB为1.03%,SLNB后行淋巴结清扫为1.40%,直接淋巴结清扫为2.80%。
- 意向性治疗分析中SLNB(±淋巴结清扫)较直接淋巴结清扫的转开腹手术风险降低(OR=0.53,95%CI 0.39-0.72);符合方案分析中仅SLNB较直接淋巴结清扫或SLNB+淋巴结清扫的OR=0.49(95%CI 0.32-0.75)。
- 住院超过1天的总体率为6.3%,SLNB的ORITT=0.51(95%CI 0.40-0.64),ORPP=0.39(95%CI 0.28-0.55);非计划再入院总体率为2.3%,ORPP=0.52(95%CI 0.33-0.81)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess the emergence of sentinel lymph node biopsy (SLNB) for disparities in utilization, and impacts on perioperative outcomes. METHODS: Retrospective cohort study of the National Cancer Database, selecting for patients with T1NxM0 endometrial cancer undergoing minimally invasive surgical staging from 2012 to 2016. Disparities in SLNB utilization were described. Propensity matching was performed. Association of SLNB with perioperative outcomes was assessed with logistic regression. RESULTS: Among 67,365 patients, 6356 (9.4%) underwent SLNB, increasing from 2.8% to 16.3% from 2012 to 2016. Disparities were identified within race (7.0% Black, 9.4% non-Black), ethnicity (8.3% Hispanic, 9.5% non-Hispanic), insurance (6.0% uninsured, 9.5% insured), county density (3.7% rural, 9.8% metro), and income (7.0% bottom-quartile, 11.8% top-quartile). Risk of conversion to open surgery was lower with SLNB alone (1.03%) or SLNB followed by LND (1.40%), versus upfront LND (2.80%). SLNB was associated with reduced risk of conversion to open surgery in Intention-To-Treat (SLNB+/-LND vs. upfront LND; ORITT = 0.53; 95%CI 0.39-0.72) and Per-Protocol (PP; SLNB alone vs. upfront LND or SLNB+LND; ORPP = 0.49; 95%CI 0.32-0.75) comparisons. SLNB was also associated with lower risk of length of stay >1 day (overall rate 6.3%; ORITT = 0.51; 95%CI 0.40-0.64; ORPP = 0.39; 95%CI 0.28-0.55), and unplanned readmission (overall rate 2.3%; ORPP = 0.52; 95%CI 0.33-0.81). There were no deaths within 90 days among 1370 SLNB alone cases, versus 2/1294 (0.15%) for SLNB+LND, and 123/28,828 (0.41%) for upfront LND. CONCLUSION: We identified significant disparities in the utilization of SLNB, as well as evidence that this less-invasive technique is associated with lower rates of certain perioperative complications. Equitable access to this emerging technique could lessen disparate outcomes.
引用
- Albright BB, Nasioudis D, Byrne ME, et al. Perioperative outcomes and disparities in utilization of sentinel lymph node biopsy in minimally invasive staging of endometrial cancer. Gynecol Oncol. 2020. PMID: 32981697. doi:10.1016/j.ygyno.2020.09.032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。